Evidera
Agkreta Leventi MSc is a skilled research professional currently serving as a Research Associate II at Evidera since October 2023. Prior experience includes roles as an Associate Researcher at Adelphi Values from July 2021 to November 2023, and as a Legal Assistant Paralegal at Bond Turner from September 2020 to June 2021. Additionally, Agkreta worked as a Mortgage Advisor at Barclays between February 2020 and August 2020 and contributed as a Research Associate at Oxford Brookes University from April 2019 to January 2020, focusing on the UK standardization of the IDS-2 Intelligence and Development Scale Assessment. Early career experience includes an internship at the Center of Systemic Psychotherapy of Thessaloniki in 2012. Agkreta holds a Master of Science in Health/Medical Psychology from Liverpool John Moores University and a Bachelor of Science in Psychology from Aristotle University of Thessaloniki.
This person is not in any teams
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.